IFI-B · Prenylflavonoid Reduction Series

Specimen SS-F-BTR-877 // ZERO-BITTER · IFI-B

Prenylflavonoid · T5 Protoplast-A

Humulus lupulus

Hops

Tier VPrenylflavonoid Reduction Series

Target Trait

74%

% reduction

Isoxanthohumol/8-PN reduction

Technical Specifications

SKU

SS-F-BTR-877

Genomic Edits

7

GC Content

44.4%

Construct Length

3,924 bp

Promoter System

35S CaMV / RbcS

Expression System

PEG-mediated protoplast transfection

Host Strain

Isolated leaf mesophyll protoplasts

Receptor Target

TAS2R38 (suppression)

IFI Score

74

Pathway Edits

  • OMT1 O-methyltransferase RNAi reduces xanthohumol-to-isoxanthohumol Cope rearrangement substrate availability
  • PrenylT prenyltransferase RNAi limits prenylation of naringenin chalcone at the C-8 position
  • CHS2 chalcone synthase isoform modification reduces xanthohumol precursor pool from phloroglucyl-CoA

Key Interventions

OMT1 methyltransferase RNAiPrenylT C-8 prenylase silencingCHS2 chalcone reduction

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
74
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier V Humulus lupulus lines for brewery applications targeting soft bitterness profiles, cosmetic and nutraceutical hop extracts requiring controlled 8-PN content, and non-alcoholic hop-flavored beverages where prenylflavonoid bitterness would detract from consumer palatability.

License

$9999 · Tier V License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?